merck & co. inc.
(MRK*:Mexico Stock Exchange)
Peter N. Kellogg BSE, MBA
Former Chief Financial Officer and Executive Vice President, Merck & Co. Inc.
|Age||Total Calculated Compensation||This person is connected to 17 board members in 2 different organizations across 6 different industries.|
See Board Relationships
As of Fiscal Year 2013
Mr. Peter N. Kellogg, BSE, MBA has been an Executive Vice President at Celgene Corporation since July 2014 and its Chief Financial Officer since August 1, 2014. Mr. Kellogg served as Executive Vice President of Merck & Co. Inc. from August 14, 2007 to May 16, 2014 and served as its the Chief Financial Officer from August 14, 2007 to April 23, 2014. He served as the Chief Financial Officer and Executive Vice President of Finance at Biogen Idec Inc. since November 2003 ...
One Merck DrivePhone: 908-423-1000
Whitehouse Station, New Jersey 08889
Board Members Memberships*
Former Chief Financial Officer and Executive Vice President
Director and Member of Audit Committee
The University of Pennsylvania
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Robert A. Bradway||Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee|
|Lamberto Andreotti||Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee|
Bristol-Myers Squibb Company
|Leonard S. Schleifer M.D., Ph.D.||Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee|
Regeneron Pharmaceuticals, Inc.
|Yoshihiko Hatanaka||Chief Executive Officer, President and Representative Director|
Astellas Pharma, Inc.
|Richard A. Gonzalez||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|$1.5M||Compensation as of Fiscal Year 2013.|